title: Impact of pneumococcal vaccination in Senegalese HIV-1-infected children.
authors.forename: Tandakha
authors.initials: T
authors.lastname: Dieye
authors.forename: Thierry
authors.initials: T
authors.lastname: Simonart
authors.forename: Papa S
authors.initials: PS
authors.lastname: Sow
authors.forename: Ngagne
authors.initials: N
authors.lastname: M'Baye
authors.forename: Souleymane
authors.initials: S
authors.lastname: M'Boup
authors.forename: Claire-Michèle
authors.initials: CM
authors.lastname: Farber
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000276:immunology* / Q000517:prevention & control*; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D003906:Developing Countries; D005260:Female; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D007109:Immunity / Q000502:physiology; D008297:Male; D011008:Pneumococcal Infections / Q000276:immunology* / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000008:administration & dosage*; D012016:Reference Values; D012675:Senegal; D014611:Vaccination; D019562:Viral Load
chemical_list: D022242:Pneumococcal Vaccines